Gene editing, also known as genome editing, allows scientists to modify the DNA of organisms using biotechnological techniques. CRISPR-Cas9 is the most widely used gene editing technology, known for ...
AZoLifeSciences on MSN
CRISPR for Christmas? The year’s biggest gene editing breakthroughs, unwrapped
In 2025, CRISPR advanced gene editing with safe, effective therapies and AI tools, marking a shift towards real-world ...
Scientists have developed a novel approach of genome editing to repair muscle stem (satellite) cells, offering new hope for ...
2don MSN
Contrarius Global Equity Fund’s thoughts on CRISPR Therapeutics’ (CRSP) gene editing therapy
Contrarius Investment Management, an investment management company, released its third-quarter investor letter for the ...
To investigate how Cas9 gene editing affected T cells, the researchers targeted the first exon of the TRAC locus, which encodes the T cell receptor on chromosome 14. As expected, DNA sequencing ...
The global prime editing and CRISPR market size was US$ 3,194.2 million in 2021. The global prime editing and CRISPR market is forecast to grow to US$ 17,618.4 million by 2030 by registering a ...
TheFly published on November 26, 2025, that Chardan kept its buy recommendation on CRISPR Therapeutics AG (NASDAQ:CRSP) while ...
Researchers have developed a novel genome editing technique known as NICER, which results in significantly fewer off-target mutations than CRISPR/Cas9 editing. The technique uses a different type of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback